Kyron.bio

Paris, France · Founded 2022 · Privately Held (backing)

Operator of a bioproduction platform intended to produce cheap and novel biopharmaceuticals. Kyron.bio is based in Paris, France and was founded in 2022. Its last reported valuation was $15 million in May 2025. It has raised $8.1 million.

Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—

Who backs Kyron.bio?

13 investors
InvestorType
Creative Destruction LabOther
BpifranceOther
European Innovation CouncilVenture capital
Entrepreneurs FirstVenture capital
European CommissionOther
Verve VenturesVenture capital
HCVCVenture capital
Saras CapitalHedge fund
EDHEC Entrepreneurs—
ESPCI Paris—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kyron.bio investors

13 investors are on record for Kyron.bio, including Creative Destruction Lab, Bpifrance, European Innovation Council and Entrepreneurs First. By type, the record holds 4 venture capital firms and 1 hedge fund.

Free account
More of Kyron.bio with a free account
  • ·The complete investor list: 13 names
  • ·Watch Kyron.bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Kyron.bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View